Floatz logo

GLUCOSE, ANHYDROUS

Liver Failure

Cliniques universitaires Saint-Luc- Université Catholique de LouvainSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Liver Failure cohort.

Asset / SponsorPhaseRating
Empagliflozin
Yale University
Phase 4BB
Avatrombopag
Tongji Hospital
Phase 4BB
Pentoxifylline
Assistance Publique - Hôpitaux de Paris
Phase 3BB
N-Acetyl-L-Cysteine
Azienda Ospedaliera di Padova
Phase 2B
Human Derived Transfer Factor
Martin Janičko
Phase 2/3CCC

View all 15 →

Same molecule, other indications

GLUCOSE, ANHYDROUS is also rated in:

Critical IllnessDormant
BB
Indicative ·
67 / 100
View asset →
injuryDormant
BB
Indicative ·
65 / 100
View asset →
metabolic diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →